Insiders Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 15:59:31 31/05/2024 BST			5-day change	1st Jan Change
927.3 ^DKK	+1.13%		-0.16%	+32.83%

05-31	Zealand Pharma Secures EU Panel Backing for Severe Hypoglycemia Treatment	MT
05-30	Danish Government Implements Stricter Subsidy Rules for Diabetes Drugs	MT

Novo Nordisk CEO: Demand for Wegovy outstrips supply	05-02	MT
Germany's Evotec appoints Christian Wojczewski as CEO	04-23	RE
Kasim Kutay, CEO of Novo Holdings: Catalent purchase marks new era of acquisitions	03-12	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	03-07
WeightWatchers shares drop as Oprah Winfrey decides to exit board	02-29	RE
Novo Nordisk CEO Jorgensen: Demand will outstrip supply for years to come	02-07	MT
Jorgensen, CEO of Novo Nordisk: €10bn investment to meet demand for its weight loss drugs	01-31	MT
Evotec says it promptly reported share trades withheld by former CEO	01-22	RE
Kasim Kutay, CEO of Novo Holdings: Acquisition Offensive	01-19	MT
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!	11-27	MT
Lars Fruergaard Jorgensen, CEO of Novo Nordisk: dose limitation to continue until 2024	11-02	MT
Novo Says Wegovy Is Growth Driver in US	11-02	MT
Recordati, Zdravkovic vice president R&D and Sabia new CMO	16/10/23	AN
Novo Nordisk Halts Ozempic Study	11/10/23	MT
INTERVIEW - PepsiCo CFO Hugh Johnston: Ozempic has no impact on sales	10/10/23	MT
BP Chair Helge Lund Won't Become New Chief Executive	15/09/23	MT
BP Chairman Withdraws from Consideration as Next CEO	15/09/23	MT
Novo-appointed director steps down from ConvaTec board	08/09/23	AN
Novo CEO on Ozempic, Wegovy Demand, Acquisition Strategy	01/09/23	MT
Evaxion Biotech Names Christian Kanstrup as CEO	29/08/23	MT